Sector consensus Changchun BCHT Biotechnology Co.

Equities

End-of-day quote Shanghai S.E. Other stock markets 2025-01-22			5-day change	1st Jan Change
22.79 ^CNY	-0.52%		-2.65%	-9.24%

10-25	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
08-16	Changchun BCHT Biotechnology H1 Profit Up 24%, Operating Income Rises 11%	MT

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Divergence of analysts' opinions	Divergence of Target Price	Average Target P.	Ecart obj. / dr	Nbr of analysts
CHANGCHUN BCHT BIOTECHNOLOGY CO.			31.99	+40.35%	2
MERCK KGAA			183.63	+26.99%	16
KYOWA KIRIN CO. LTD.			3,057.69	+33.67%	13
HALOZYME THERAPEUTICS, INC.			64.75	+17.13%	8
YUHAN CORPORATION			139,083.33	+7.48%	12
SK BIOPHARMACEUTICALS CO., LTD.			123,642.86	+13.64%	14
BETTA PHARMACEUTICALS CO., LTD.			56.83	-0.86%	3
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	-	-	19.52	+68.86%	1
SUPERNUS PHARMACEUTICALS, INC.			42.80	+12.13%	5
INDIVIOR PLC			16.30	+36.01%	5
KISSEI PHARMACEUTICAL CO., LTD.			4,033.33	+4.63%	3
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	-	-	37.60	+120.53%	1
YOUCARE PHARMACEUTICAL GROUP CO., LTD.	-	-	28.00	+93.37%	1
CORMEDIX INC.			16.20	+31.71%	5
HK INNO.N CORPORATION			60,923.08	+67.14%	13
OSCOTEC INC.	-		56,000.00	+109.74%	2
Average			24,202.37	+42.66%	6
Weighted average by Cap.			16,628.11	+26.83%	13